[Severe aplastic anaemia in six children after non-A-E hepatitis without hepatic failure]

E Tschiedel1, N Gierenz, R Wieland

  • 1Kinderklinik, Universitätskinderklinik Essen. eva.tschiedel@uni-due.de

Zeitschrift Fur Gastroenterologie
|August 6, 2010
PubMed

Insights

Aplastic anemia often follows non-A-E hepatitis, particularly in children. Early blood testing after hepatitis is crucial for timely diagnosis and treatment of this serious condition.

Area of Science:

  • Pediatric Hematology
  • Hepatology
  • Infectious Diseases

Background:

  • Aplastic anemia is a rare but serious condition where the bone marrow doesn't produce enough blood cells.
  • Non-A-E hepatitis encompasses viral hepatitis types not screened for in standard blood donations.
  • The co-occurrence of aplastic anemia and non-A-E hepatitis, especially in pediatric cases, warrants further investigation.

Observation:

  • This study details six pediatric cases of aplastic anemia following non-A-E hepatitis.
  • Four patients initially presented with acute gastroenteritis, suggesting a potential infectious trigger.
  • Treatment protocols involved immunosuppression and/or bone marrow transplantation, guided by the German Society of Pediatric Oncology and Hematology (GPOH).

Findings:

  • Five out of six children achieved full recovery.
  • Two patients recovered with immunosuppression alone; three required bone marrow transplantation.
  • One patient succumbed to complications related to bone marrow transplantation.
  • Steroid therapy for hepatitis showed no impact on aplastic anemia progression.

Implications:

  • Highlights the significant association between non-A-E hepatitis and aplastic anemia in children.
  • Underscores the importance of regular hematological monitoring post-non-A-E hepatitis diagnosis.
  • Suggests a potential infectious etiology for aplastic anemia, possibly linked to preceding gastroenteritis.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...